Metagenomi Therapeutics to Present Preclinical Data on MGX-001 at Hematology Meeting

Metagenomi plans an oral presentation of preclinical data on MGX-001, a potential one-time therapy for hemophilia A, at the 68th American Society of Hematology Annual Meeting.